Abstract: The present invention provides devices and methods for capturing rare cells. The devices and methods described herein can be used to facilitate the diagnosis and monitoring of metastatic cancers.
Type:
Application
Filed:
March 18, 2010
Publication date:
January 5, 2012
Applicant:
The Regents of the University of California
Inventors:
Hsian-Rong Tseng, Shutao Wang, Hao Wang, Kan Liu
Abstract: Nanoparticles for use in the collection, concentration, isolation and storage of biomolecules from biological samples are provided. More specifically, nanoparticles used to isolate biomolecules, including nucleic acids and proteins, cells, cell fragments, bacteria, and viruses from biological samples such as urine, cerebrospinal fluid (CSF), mouthwash samples, and amniotic fluid are provided. Kits for using nanoparticles for the isolation of biomolecules are also provided.
Type:
Application
Filed:
February 21, 2011
Publication date:
January 5, 2012
Inventors:
Barbara Dawn Leinweber, Paul E. Diggins
Abstract: A high-sensitivity field effect transistor using as a channel ultrafine fiber elements such as carbon nanotube, and a biosensor using it. The field effect transistor comprises a substrate, a source electrode and a drain electrode arranged on the substrate, a channel for electrically connecting the source electrode with the drain electrode, and a gate electrode causing polarization due to the movement of free electrons in the substrate. For example, the substrate has a support substrate consisting of semiconductor or metal, a first insulating film formed on a first surface of the support substrate, and a second insulating film formed on a second surface of the support substrate, the source electrode, the drain electrode, and the channel arranged on the first insulating film, the gate electrode disposed on the second insulating film.
Type:
Grant
Filed:
December 13, 2007
Date of Patent:
December 6, 2011
Assignees:
Mitsumi Electric Co., Ltd., Semicon Craft Technologies
Abstract: The present disclosure provides devices for neuronal growth and associate methods. In one aspect, for example, a neuronal growth device is provided including a layer of nanodiamond particles having an exposed neuronal growth surface, a doped diamond layer contacting the layer of nanodiamond particles opposite the neuronal growth surface, and a semiconductor layer coupled to the doped diamond layer opposite the layer of nanodiamond particles. In one aspect, the nanodiamond particles are substantially immobilized by the doped diamond layer.
Abstract: An imaging apparatus comprising a ring-shaped gantry is provided. The gantry has a rotor arrangement rotating therein and a radiation source as well as at least one radiation detector. The gantry has at least one gantry segment which can be detached from the ring shape to allow the gantry to be opened laterally. The gantry is arranged on a supporting structure so as to be movable in space. The supporting structure is a floor, wall or ceiling mounted articulated-arm robot having at least four, preferably six, degrees of freedom of movement. The gantry has at least two radiation sources disposed offset by an angle on the rotor arrangement and associated with each of which is at least one radiation detector.
Abstract: A computed tomography system is provided for allowing it to be deployed more effectively. The computed tomography system features an annular CT gantry with a central opening, a recording system that can be rotated within the gantry. The recording system has an x-ray source and an x-ray detector apparatus. It is possible to remove a part of the ring of the CT gantry from the ring at least partially so that there is a break in the ring, through which an examination object can be moved into the central opening. The computed tomography system is for phase contrast x-ray imaging.
Abstract: Fibers, fabrics and textiles in which core-shell silica nanoparticles are incorporated are provided. The fibers, fabrics and textiles can be polymeric materials or natural cellulose-based or protein-based materials in which core-shell silica nanoparticles are incorporated. A variety of polymeric and natural materials can be employed, such as cellulose acetate, nylon, rayon, modacrylic, olefin, acrylic, polyester, polylactic acid, polylactic-co-glycolic acid (PLGA), polyurethane, aramid, wool, cotton, ramie, milk protein, soy protein, bamboo, etc. The core-shell silica nanoparticles can incorporate sensing, magnetic, thermal, electrical, chemical or RFID properties that can be imparted to the materials and that allow the materials to sense one or more conditions of interest, making them ideal for in situ sensing, treatment, or security applications.
Type:
Application
Filed:
May 12, 2009
Publication date:
October 27, 2011
Inventors:
Erik Herz, Erin Sue Hendrick, Margaret W. Frey, Ulrich Wiesner
Abstract: The invention generally relates to conducting an assay on a sample that isolates a pathogen from the sample and allows for analysis of the pathogen with minimal (i.e., at most 24 hrs of culturing) or no culturing of the pathogen. In certain embodiments, the invention provides methods for identifying a pathogen from a sample that involve obtaining a sample including a pathogen, conducting an assay that isolates the pathogen from the sample, culturing the isolated pathogen for at most about 24 hrs, and analyzing the pathogen.
Type:
Application
Filed:
April 21, 2011
Publication date:
October 27, 2011
Applicant:
NANOMR, INC.
Inventors:
Sergey A. Dryga, Lisa-Jo Ann Clarizia, Eddie W. Adams, Victor C. Esch
Abstract: The present invention relates to a method for preparing a ferrite superparamagnetic nano particle engineered by magnesium doping, and a technique for applying it to hyperthermia cancer cell treatment and the heat shock protein (HSP) self-defense mechanism.
Abstract: The invention provides methods for the identification of small molecules that inhibit MUC1 oligomerization, and the functions flowing therefrom. In addition, small molecules that prevent MUC1 oligomerization are disclosed. Identified molecules will find use in treating a variety of MUC1-related inflammatory conditions, including MUC1-related cancers.
Abstract: A wireless system for neurological and physiological monitoring of a patient. The system includes a patient monitoring unit having a headcap and a belt. The headcap includes a wireless communication module, an antenna, and an amplifier. The headcap further includes at least one of a biopotential electrode, a temperature sensor, a rotation sensor, an accelerometer, and an airflow sensor. The belt includes a respiration sensor comprising a carbon nanotube-based strain sensor. The system also includes a base receiver-server unit including a wireless receiving unit, a data storage unit, and a network communications unit. The system also includes a client monitoring unit which includes a processor, a network communications unit operably coupled to the processor, and a storage medium operably coupled to the processor, wherein the storage medium includes program instructions executable by the processor for receiving and processing data from the patient monitoring unit.
Type:
Application
Filed:
April 9, 2010
Publication date:
October 13, 2011
Applicant:
THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
Abstract: Blood plasma of pregnant women contains fetal and (generally>90%) maternal circulatory extracellular DNA. Most of said fetal DNA contains ?500 base pairs, said maternal DNA having a greater size. Separation of circulatory extracellular DNA of <500 base pairs results in separation of fetal from maternal DNA. A fraction of a blood plasma or serum sample of a pregnant woman containing, due to size separation (e.g. by chromatography, density gradient centrifugation or nanotechnological methods), extracellular DNA substantially comprising ?500 base pairs is useful for non-invasive detection of fetal genetic traits (including the fetal RhD gene in pregnancies at risk for HDN; fetal Y chromosome-specific sequences in pregnancies at risk for X chromosome-linked disorders; chromosomal aberrations; hereditary Mendelian genetic disorders and corresponding genetic markers; and traits decisive for paternity determination) by e.g. PCR, ligand chain reaction or probe hybridization techniques, or nucleic acid arrays.
Type:
Application
Filed:
February 17, 2011
Publication date:
October 6, 2011
Applicant:
SEQUENOM, INC.
Inventors:
Sinuhe Hahn, Wolfgang Holzgreve, Bernhard Zimmermann, Ying Li
Abstract: Certain disclosed embodiments of the present invention concern the synthesis, derivatization, conjugation to immunoglobulins and signal amplification based on discrete, relatively short polymers having plural reactive functional groups that react with plural molecules of interest. Reactive functional groups, such as hydrazides, may be derivatized with a variety of detectable labels, particularly haptens. The remaining reactive functional groups may be conjugated directly to a specific binding molecule, such as to the oxidized carbohydrate of the Fc region of the antibody. Disclosed conjugates display large signal amplification as compared to those based on molecules derivatized with single haptens, and are useful for assay methods, particularly multiplexed assays.
Type:
Application
Filed:
April 29, 2011
Publication date:
October 6, 2011
Inventors:
Jerry W. Kosmeder, Casey A. Kernag, Donald Johnson, Christopher Bieniarz
Abstract: The invention relates to a method for detecting the presence or amount of an analyte, said method comprising (a) coupling the analyte to a carrier molecule, wherein the carrier molecule is larger in size, electrically charged and/or polar, to form an analyte:carrier molecule complex; (b) contacting the analyte:carrier molecule complex of (a) with an analyte-binding molecule coupled to a semiconducting nanostructure; and (c) determining the change in conductance upon binding of the analyte:carrier molecule complex to the analyte-binding molecule and correlating the determined change in conductance to the presence or amount of the analyte. Alternatively, the analyte:carrier molecule complex of (a) is immobilized on the nanostructure and the immobilized analyte:carrier molecule complex is contacted with the analyte-binding molecule.
Type:
Application
Filed:
March 11, 2011
Publication date:
September 29, 2011
Applicants:
Agency for Science, Technology and Research, Nanyang Technological University
Inventors:
Ju Nie Tey, I Putu Mahendra Wijaya, Jun Wei, Isabel Rodriguez, Subodh Mhaisalkar
Abstract: A method of forming an implant to be implanted into living bone is disclosed. The method comprises the act of roughening at least a portion of the implant surface to produce a microscale roughened surface. The method further comprises the act of immersing the microscale roughened surface into a solution containing hydrogen peroxide and a basic solution to produce a nanoscale roughened surface consisting of nanopitting superimposed on the microscale roughened surface. The nanoscale roughened surface has a property that promotes osseointegration.
Abstract: A suspendable SERS nanotag. As used herein, a suspendable tag is one which remains suspended in a specific liquid, water for example, for a period of time. Thus, a suspendable tag does not sink to the bottom of a container of the liquid or float to the top of a container of the liquid within the selected time period. A suspendable SERS nanotag may include a metal core, for example, an Au core having a diameter of less than 90 nm. The suspendable SERS nanotag may also include a SERS active reporter molecule associated with the core and a silica containing encapsulant, encapsulating the core and reporter association.
Abstract: The present invention relates to a method of exposing particles to cytoplasm comprising introducing particles into a live cell; allowing the live cell to contact a cytoplasm exposure additive which can expose the particles from endocytic vesicles to cytoplasm in the cell with maintaining its physiological, biochemical, or biological environment as undamaged; and allowing the particles to be exposed from the endocytic vesicles to the cytoplasm. The present invention is advantageous in that particles delivered into cells can be effectively exposed to cytoplasm from endocytic vesicles in intact cells which maintain their physiological, biochemical, or biological environment as undamaged.
Abstract: A device and method detect cellular targets in a bodily source by utilizing a biofunctional pad comprised of a thin film of carbon nanotubes (CNT's). When antibodies are absorbed by the CNT's, cellular targets having markers matching the antibodies may be detected in a bodily source placed upon the biofunctional pad by measuring the conductivity of the thin film using conductive contacts electrically coupled to the thin film, as the binding of the receptors in the cellular targets to the antibodies changes the free energy in the thin film. In many respects, the device functions as a Field Effect Transistor (FET) with the bodily source, e.g., blood, acting as a polyelectrolyte liquid gate electrode to create a varying electrostatic charge or capacitance in the thin film based upon the binding of cellular targets in the source to the antibodies present on the biofunctional pad.
Type:
Application
Filed:
March 10, 2011
Publication date:
September 15, 2011
Applicant:
UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.
Abstract: A device and method for generating microcapsules employs an inertial-focusing channel for introducing particles dispersed in a prepolymer suspension fluid, a droplet-generating junction for introducing oil evenly onto the flow of particles to create separated droplets of prepolymer suspension fluid encapsulating respective particles in a streamline flow, and a polymerization section for exposing the droplets to UV light or heat to cause polymerization of a polymer coating on separate microcapsules each containing a respective particle. Preferred suspension fluids may be aqueous solution of poly(ethylene-glycol)-diacrylate (PEGDA), or poly(N-isopropyl-acryalmide) (PNIPAAM). The preferred device may employ a curved or linear inertial-focusing microchannel. Functional tags and/or handles may be added to the microcapsules allowing easy detection, measurement and handling of the microcapsules.
Type:
Application
Filed:
March 10, 2011
Publication date:
September 15, 2011
Inventors:
Xiaoxiao ZHANG, David Garmire, Aaron Ohta
Abstract: This application is for a device using aptamers, multiwalled carbon nanotubes (MWCNTs) filled with nanosized iron oxide particles immobilized magnetically on a stent by a magnet and then subsequently killing circulating tumor cells (CTCs) attached to the aptamers by heating the carbon nanotubes with near infrared (NIR) lasers and then release from the stent by removing the permanent magnet and subsequent excretion of the MWCNTs.
Abstract: Hair fixatives such as styling mousse and gel may include biopolymers derived from natural renewable resources. The biopolymer may be cross linked to form a biopolymer latex that may be incorporated into the hair fixatives.
Type:
Application
Filed:
February 28, 2011
Publication date:
September 1, 2011
Applicant:
HONEYWELL INTERNATIONAL INC.
Inventors:
Mark Richard Wheeler, Philip Orawski, Malena Higuera, Lee Mores
Abstract: Compositions comprising a nanoparticulate corticosteroid and an antihistamine are described. The compositions are useful in the prophylaxis and chronic treatment of asthma in adults and pediatric patients and for the relief of allergic conjunctivitis, symptoms of seasonal allergic rhinitis in adults and pediatric patients. Combining an antihistamine with a nanoparticulate corticosteroid in a single formulation results in improved efficacy.
Type:
Grant
Filed:
March 23, 2006
Date of Patent:
August 23, 2011
Assignee:
Elan Pharma International Limited
Inventors:
Gary Liversidge, Scott Jenkins, H. William Bosch, Christian F. Wertz
Abstract: An article for use in an OCT method, the article comprising a solid substrate and nanoparticles dispersed in or on the substrate in at least one light transmissive portion of the article such that the nanoparticles result in an increased extinction of the light transmissive portion along a transmission direction of the light transmissive portion compared to the substrate being free of nanoparticles. The extinction of the light transmissive portion along the transmission direction is less than 6, wherein the extinction is defined as a negative decadic logarithm of a ratio of an intensity of light which is transmitted through the light transmissive portion to an intensity of light which is incident on the light transmissive portion, wherein the light is in at least one of a visible and a near infrared wavelength range.
Type:
Application
Filed:
August 17, 2010
Publication date:
August 18, 2011
Applicant:
Carl Zeiss Surgical GmbH
Inventors:
Marco Wilzbach, Martin Hacker, Christoph Hauger
Abstract: This invention relates to SPPs, spherical nanocrystalline composite particles or crystalline SPPs of biologically active proteins or compositions, including formulations, comprising such SPPs, spherical nanocrystalline composite particles or crystalline SPPs. More particularly, methods are provided for the production of SPPs, spherical nanocrystalline composite particles or crystalline SPPs of high concentrations of biologically active proteins, and for the preparation of stabilized SPPs, spherical nanocrystalline composite particles or crystalline SPPs for use alone, or in dry or slurry compositions. This invention also relates to methods for stabilization, storage and delivery of biologically active proteins using SPPs, spherical nanocrystalline composite particles or crystalline SPPs.
Type:
Grant
Filed:
December 19, 2003
Date of Patent:
August 16, 2011
Assignee:
Althea Technologies Inc.
Inventors:
Kirill Yakovlevsky, Michael Shamashkin, Nazer Khalaf, Chandrika P. Govardhan, Chu W. Jung
Abstract: The invention provides a system and process of patterning structures on a carbon based surface comprising exposing part of the surface to an ion flux, such that material properties of the exposed surface are modified to provide a hard mask effect on the surface. A further step of etching unexposed parts of the surface forms the structures on the surface. The inventors have discovered that by controlling the ion exposure, alteration of the surface structure at the top surface provides a mask pattern, without substantially removing any material from the exposed surface. The mask allows for subsequent ion etching of unexposed areas of the surface leaving the exposed areas raised relative to the unexposed areas thus manufacturing patterns onto the surface. For example, a Ga+ focussed ion beam exposes a pattern onto a diamond surface which produces such a pattern after its exposure to a plasma etch.
Type:
Application
Filed:
July 3, 2009
Publication date:
August 4, 2011
Applicant:
THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE O F THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABE
Inventors:
Graham L. W. Cross, Warren McKenzie, John B. Pethica
Abstract: A single-electron transistor comprising at least a substrate, a source electrode and a drain electrode formed on top of the substrate opposing to each other, and a channel arranged between the source electrode is disclosed wherein the channel is composed of ultra fine fibers. By having such a constitution, a sensor can have excellent sensitivity.
Type:
Application
Filed:
April 6, 2011
Publication date:
July 28, 2011
Applicants:
Japan Science and Technology Agency, National Institute of Advanced Industrial Science and Technology
Abstract: The present invention relates to a targeted magnetic nanoparticle drug and the preparation method thereof. The targeted magnetic nanoparticle drug comprises an effector molecule and a guidance molecule in a weight ratio of 1:0.0001-0.20. The aforesaid effector molecule is a magnetic particle, with a particle size of not more than 1000 nm and a specific adsorption rate (SAR) of 10-7000 W/gFe. The aforesaid guidance molecule comprises an antibody, a ligand or a magnetic particle. The particle size of the aforesaid targeted drug is 2-1000 nm. The targeted magnetic nanoparticle drug is prepared by coupling a magnetic particle and a guidance molecule in a weight ratio of 1:0.0001-0.20 in water, organic or inorganic substance or the mixed solution thereof. The resultant targeted magnetic nanoparticle drug can realize targeted magnetic hyperthermia treatment and targeted magnetic thermoablation treatment and prevention on the tumors, and effectively kill the cancer cells, and cure the malignant tumors.
Abstract: A method for detecting a target analyte associated with nano-sized gold- and/or silver-containing detecting labels in a microarray of samples. The labels indicate presence or absence of a target analyte in a sample. The method includes sequentially illuminating at least two sample groups with at least two different monochromatic light beams. The sample groups include (a) a first sample group containing at least one sample potentially containing the target analyte, and (b) a second sample group serving as positive control or negative control. The method also includes (ii) detecting intensity of light reflected, absorbed, or emitted from each of the sample groups when illuminated with each of the monochromatic light beams. (iii) recording groups of values associated with the intensity reflected, absorbed, or emitted light. (iv) comparing the groups of values associated with the sample groups; and (v) determining the presence of the target analyte based on the comparison.
Abstract: A system and method for tomosynthesis, the method including emitting a respective imaging x-ray from each of a plurality of imaging x-ray sources disposed in a fixed relation with respect to one another, acquiring x-ray absorption projections of an object, each of the x-ray absorption projections associated with an imaging x-ray emitted by a respective one of the plurality of imaging x-ray sources, and performing digital tomosynthesis using the x-ray absorption projections to generate a cross-sectional image of the object.
Abstract: Devices, compositions, and methods are described which provide a tubular nanostructure or a composite tubular nanostructure targeted to a lipid bilayer membrane. The tubular nanostructure includes a hydrophobic surface region flanked by two hydrophilic surface regions. The tubular nanostructure is configured to interact with a lipid bilayer membrane and form a pore in the lipid bilayer membrane. The tubular nanostructure may be targeted by including at least one ligand configured to bind to one or more cognates on the lipid bilayer membrane of a target cell.
Type:
Application
Filed:
September 15, 2008
Publication date:
July 21, 2011
Inventors:
Mahalaxmi Gita Bangera, Ed Harlow, Roderick A. Hyde, Muriel Y. Ishikawa, Edward K.Y. Jung, Eric C. Leuthardt, Nathan P. Myhrvold, Dennis J. Rivet, Elizabeth A. Sweeney, Clarence T. Tegreene, Lowell L. Wood, JR., Victoria Y.H. Wood
Abstract: Provided are fabrication, characterization and application of a nanodisk electrode, a nanopore electrode and a nanopore membrane. These three nanostructures share common fabrication steps. In one embodiment, the fabrication of a disk electrode involves sealing a sharpened internal signal transduction element (“ISTE”) into a substrate, followed by polishing of the substrate until a nanometer-sized disk of the ISTE is exposed. The fabrication of a nanopore electrode is accomplished by etching the nanodisk electrode to create a pore in the substrate, with the remaining ISTE comprising the pore base. Complete removal of the ISTE yields a nanopore membrane, in which a conical shaped pore is embedded in a thin membrane of the substrate.
Type:
Application
Filed:
November 18, 2010
Publication date:
July 14, 2011
Applicant:
THE UNIVERSITY OF UTAH RESEARCH FOUNDATION
Inventors:
Henry S. White, Bo Zhang, Ryan J. White, Eric N. Ervin, Gangli Wang
Abstract: A method and apparatus for identifying and tracking surgical objects is disclosed. More specifically, a method and apparatus for identifying and tracking surgical objects such as needles, scalpels, blades, sponges and instruments in a medical industry using an identifier encoded on a fluorescent paint attached to the surgical object combined with detectors and software capable of retrieving the identifying information on the identifier.
Type:
Application
Filed:
September 2, 2009
Publication date:
July 7, 2011
Applicant:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Inventors:
Thomas Hamelin, Niren Angle, Milan Makale, Wolf Wrasidlo, Sadik C. Esener
Abstract: A method of uncoupling mitochondria in a subject including administering nanotubes to the subject in a therapeutically effective amount, wherein the nanotubes are self-rectifying is provided. A method of decreasing reactive oxygen species and decreasing detrimental loading of Ca2+ into mitochondria is provided, including administering a pharmaceutically effective amount of nanotubes into the subject. A method of reducing weight, treating cancer, reducing the effects of traumatic brain injury, or reducing the effects of ageing, in a subject including administering a pharmaceutically effective amount of nanotubes into the subject is also provided.
Type:
Application
Filed:
February 25, 2011
Publication date:
June 30, 2011
Applicant:
University of Kentucky Research Foundation
Abstract: A treatment apparatus using proton includes a proton generation unit and a magnet. The proton generation unit projects proton into a tumor site of a patient, and the magnet forms a magnetic field around the patient. The proton conducts a spiral motion due to collision with atom of the tumor site and Lorenz force generated by the magnetic field.
Type:
Application
Filed:
July 14, 2010
Publication date:
June 23, 2011
Applicant:
Electronics and Telecommunications Research Institute
Inventors:
Moon Youn Jung, Nam Soo Myung, Hyun Woo Song, Hyeon-Bong Pyo
Abstract: This invention discloses a new conjugate compound that comprises at least one HA oligomer derivatised through one thiolated linker, whereby it binds to at least one metal nanoparticle, such as, for example, a gold nanoparticle. Moreover, it discloses methods of obtaining it, as well as the use thereof in a cosmetic treatment, and cosmetic compositions that contain them.
Type:
Application
Filed:
January 5, 2009
Publication date:
June 16, 2011
Inventors:
Marc Ramis Castelltort, Isaac Ojea Jimenez, Joaquin Querol Sastre
Abstract: This invention discloses methods and apparatus for providing a biomedical device, such as an ophthalmic lens with an energy receptor capable of powering a processing device. The energy receptor can include a conductive material deposited onto a media and placed within a mold used to form the biomedical device. In some embodiments, the conductive material is ink jetted onto the media.
Abstract: A fixative for biological tissue made up of polymerized carbon nanotubes encapsulating osmium nanoparticles and its method of synthesis are disclosed. Carbon nanotubes are first oxidized. Next, the oxidized carbon nanotubes and monohydrated citric acid are mixed to synthesize carbon nanotubes grafted with poly(citric acid). The carbon nanotubes grafted with poly(citric acid) are then mixed with an osmium source to synthesize carbon nanotubes grafted with poly(citric acid) encapsulating osmium nanoparticles. The nano-fixative of this application has been shown to improve fixation of biological tissue relative to well-known fixatives.
Abstract: A nutritional beverage or drink is provided having resveratrol mixed with water, suspended in a liquid suspension system. One or more of quercetin, catechins, antioxidants, energy agents, sweeteners, preservatives, pH balancing ingredients, and coloring agents may also be included. A process is provided for preparing a dietary supplement drink in a liquid suspension, comprising mixing water in a suspension system with resveratrol. The process may also include adding one or more of quercetin, catechins, antioxidants, energy agents, sweeteners, preservatives, acidulants, and coloring agents. The nutritional beverage or drink may also be modified by using pure water that has nanosized water clusters therein, as well as mixing into the liquid suspension nanoparticles of resveratrol and/or one or more of the above ingredients to enhance the bioavailability of the ingredients. The compositions may be used to treat diseases and bodily malfunctions.
Abstract: A silicone rubber exhibiting antimicrobial efficacy contains: a) at least one silicone rubber derived from a curable silicone rubber-forming composition; b) at least one silver-containing antimicrobial agent incorporated in silicone rubber (a) in X weight percent amount; and, c) at least one carboxylic acid incorporated in silicone rubber (a) in Y weight percent amount, silver-containing antimicrobial agent (b) when incorporated by itself in silicone rubber (a) in an amount of X+Y weight percent therein and carboxylic acid (c) when incorporated by itself in silicone rubber (a) in an amount of X+Y weight percent therein imparting no significant antimicrobial activity to silicone rubber (a) but in the combination therein of up to X weight percent silver-containing antimicrobial agent (b) and up to Y weight percent carboxylic acid (c) imparting significant antimicrobial activity to silicone rubber (a), such activity being exhibited at the interface of an exposed surface of silicone rubber (a) and a microbe-popul
Abstract: Methods and systems for producing a change in a medium. A first method and system (1) place in a vicinity of the medium at least one upconverter including a gas for plasma ignition, with the upconverter being configured, upon exposure to initiation energy, to generate light for emission into the medium, and (2) apply the initiation energy from an energy source including the first wavelength ?1 to the medium, wherein the emitted light directly or indirectly produces the change in the medium. A second method and system (1) place in a vicinity of the medium an agent receptive to microwave radiation or radiofrequency radiation, and (2) apply as an initiation energy the microwave radiation or radiofrequency radiation by which the agent directly or indirectly generates emitted light in the infrared, visible, or ultraviolet range to produce at least one of physical and biological changes in the medium.
Type:
Application
Filed:
November 10, 2010
Publication date:
May 19, 2011
Applicants:
Immunolight, LLC, Duke University
Inventors:
Frederic A. Bourke, JR., Zakaryae Fathi, Ian Nicholas Stanton, Michael J. Therien, Paul Rath Stauffer, Paolo MacCarini, Katherine Sarah Hansen, Diane Renee Fels, Cory Robert Wyatt, Mark Wesley Dewhirst
Abstract: The present invention relates to biodegradable medical devices such as stents manufactured from biodegradable polymeric-bioceramic nanoparticle composites. The invented medical devices include at least one bioceramic nanoparticle dispersed in at least one biodegradable polymer, wherein the said biodegradable polymers include biodegradable polyesters. The device and methods to disperse one or more bioceramic nanoparticle, wherein the said bioceramic nanoparticle include, but are not limited to, amorphous calcium phosphate (ACP), dicalcium phosphate (DCP), tricalcium phosphate (TCP), pentacalcium hydroxyl Apatite (HAp), tetracalcium phosphate monoxide (TTCP) and combinations or analogues thereof. Other embodiments include methods of fabricating biodegradable stent with said polymeric-nanoparticle composites.
Abstract: A method for covalently binding target molecules to carbon nanoparticles via at least one bridge molecule includes converting carbon nanoparticles to acyl carbon nanoparticles using a carbonyl compound of the at least one bridge molecule in the presence of a Lewis acid under Friedel-Crafts conditionsm, where the acyl carbon nanoparticles include a nucleofuge in the omega position. The target molecule is covalently bound to the acyl carbon nanoparticles via nucleophilic substitution of the nucleofuge in the omega position.
Type:
Application
Filed:
October 27, 2010
Publication date:
May 12, 2011
Applicant:
KARLSRUHER INSTITUT FUER TECHNOLOGIE
Inventors:
Teodor Silviu Balaban, Stefanie Potratz, Frank Hennrich, Regina Fischer, Michaela Carmen Balaban, Manfred Kappes
Abstract: Method and system for detecting presence of biomolecules in a selected subset, or in each of several selected subsets, in a fluid. Each of an array of two or more carbon nanotubes (“CNTs”) is connected at a first CNT end to one or more electronics devices, each of which senses a selected electrochemical signal that is generated when a target biomolecule in the selected subset becomes attached to a functionalized second end of the CNT, which is covalently bonded with a probe molecule. This approach indicates when target biomolecules in the selected subset are present and indicates presence or absence of target biomolecules in two or more selected subsets. Alternatively, presence of absence of an analyte can be detected.
Type:
Grant
Filed:
June 14, 2004
Date of Patent:
May 10, 2011
Assignee:
The United States of America as represented by the Administrator of the National Aeronautics and Space Administration (NASA)
Inventors:
Jun Li, Meyya Meyyappan, Alan M. Cassell
Abstract: Nanoparticle-sized magnetic absorption enhancers (MAEs) that exhibit a controlled response to a magnetic field, including a controlled mechanical response and inductive thermal response. The MAEs have a magnetic material that exhibits the inductive thermal response to the magnetic field and is embedded in a coating, such that the MAE conforms to a particular shape, e.g., a hemisphere, a dome or a shell, that is chosen to produce the desired controlled mechanical response of the entire MAE to the magnetic field. A targeting moiety for specifically binding the MAE to a pathogen target is also provided. The MAEs are preferably bound by a flexible linker to promote the desired mechanical response, which includes interactions between MAEs that are not bound to their pathogen target for the purpose of forming spheres, spherical shells, or generally spherical dimers.
Abstract: The invention refers to the use of the PAT nonapeptide which is a thymuline analog in the treatment of autoimmune diseases, in particular of rheumatoid arthritis and intestinal bowel diseases (IBD) such as the Crohn's disease.
Abstract: A concept of high resolution electrophoretic technique, apparatus and its application thereof. The system is a functioning entity in a radial-flat setting. Unlike the conventional rectangular gel-electrophoresis setup, wherein two electrically opposite poles are placed on opposite sites of a rectangular gel, the novel system places one of the electrical poles in the middle of the gel and the outer rims of the radial gel is exposed to the other pole. The point, central pole (positive/negative) and the radial (negative/positive) pole around the outer rim of the gel will create and maintain a gradient electric field, wherein the intensity of the electric field increases towards the central pole with an inverse proportionally to the decrease in the surface area towards the center in a radial-gradient setting.
Abstract: Ligand-capped nanoparticles are dispersed in an organic solvent. There is then phase transfer of the nanoparticles introducing into the organic solvent an aqueous solution of polymer surfactant dissolved in water. The organic solvent and the aqueous solution are then mixed until the polymer forms micelles which encapsulate the nanoparticles in assemblies. The resultant nanoparticle assemblies in an aqueous phase may be used for any of a range of desired applications. It has been found that the assembly size can be tuned by control of any or a combination of method parameters such as concentration of polymer surfactant, and/or temperature of the phase change reaction, and/or rate of mixing, such as rotational rate of stirring. The nanoparticle assemblies find particular application as fluorescent biomarkers.
Type:
Application
Filed:
October 5, 2010
Publication date:
April 21, 2011
Inventors:
Kevin M. Ryan, Ambarish Sanyal, Timothy McGloughlin, Anna V. Piterina
Abstract: Systems and methods for performing transmission microscopy on a sample material are disclosed. The sample material is placed on a metal nanoparticle substrate. High intensity light, such as an infrared laser, is focused on the nanoparticle substrate, thereby exciting the silver nanoparticles. The excited nanoparticles emit intensely focused, spectrally broad white light that is able to pass through the sample material without significant scattering even when the sample material is highly diffuse. The emitted light that passes through the sample material is detected and used to generate images and characterize features of the sample material, including the internal structural composition of the sample material.
Type:
Grant
Filed:
July 10, 2009
Date of Patent:
April 19, 2011
Assignee:
University of Utah Research Foundation
Inventors:
John Mark Lupton, Michael H. Bartl, Debansu Chaudhuri, Jeremy Galusha, Nicholas Borys, Manfred Josef Walter
Abstract: A miniature X-ray tube for intravascular or intracorporeal radiation treatment in living beings is proposed. The X-ray tube comprises a cylindrical housing section with a longitudinal axis. The miniature X-ray tube also comprises a cylindrical or cylindrical-tube-shaped first field emission cathode arranged concentrically about the longitudinal axis in the housing with a plurality of carbon nanotubes which emit electrons radially outward. The miniature X-ray tube also comprises a second field emission cathode in the housing with a plurality of carbon nanotubes which emit electrons in the direction of longitudinal axis. The miniature X-ray tube only emits little heat and is robust against mechanical stresses.